Purple Heart Veteran Received a Brand-New Smile for Veteran’s Day Using Yomi Robotics at Berks Oral Surgery and Dental Implant Center
WYOMISSING, Pa., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Carl Pettinato was only 17 when he enlisted in the US Navy....
Day: November 14, 2020
CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza
One-dose, oral Xofluza has been recommended for approval for the treatment of uncomplicated influenza in patients aged 12 years and...
Apellis Announces Late-Breaking Presentation of Largest Retrospective Database Study in Geographic Atrophy (GA) at AAO 2020 Virtual
Verana Health analysis of American Academy of Ophthalmology IRIS® Registry presented in a late-breaking oral session Real-world clinical data show...
MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers...
Inari Medical Announces Presentation of Positive 30-Day Follow-Up Results from First Patients in Real World FLASH Registry
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused...
Braingrid Limited Announces Completion of Share Consolidation
TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”), is pleased to announce that...
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association’s Virtual Scientific Sessions 2020
VASCEPA®, compared with placebo, significantly reduced primary composite first and total major adverse cardiovascular events (MACE) in post hoc exploratory...
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) by...
AnaptysBio to Present at the 2020 Jefferies London Virtual Healthcare Conference
SAN DIEGO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product...
Todos Medical CEO Provides Corporate Update
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company...
Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020
BOSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief...
Litchfield Hills Research Initiates Analyst Coverage of USA Equities Corp. (USAQ)
West Palm Beach, FL, Nov. 13, 2020 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), and its wholly owned subsidiary...
Cassava Sciences Announces Pricing of $75 Million Public Offering of Common Stock
AUSTIN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage...